Proviva Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Proviva Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors (NCT06190886) | Proviva Therapeutics, Inc. | 2024-06-11 |
Track Proviva Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.